Melissa Gilliam, MD, MPH:
is the Section Chief for the Section of Family Planning and Contraceptive Research in the Department of Obstetrics and Gynecology at the University of Chicago. Dr. Gilliam has initiated several community based research projects that seek to identify adolescent attitudes towards sexual activity, pregnancy and contraceptive practices. Specifically, her work focuses on Latina and African American teens and their experience with unintended pregnancy, rapid repeat pregnancy and oral contraceptive use. She also serves as the principal investigator on clinical trials designed to test the safety, efficacy, and/or acceptability of different birth control methods (vaginal rings, contraceptive patch, new birth control pills, etc.)
Studies under the direction of Dr. Gilliam
  Arthur Herbst, MD:
investigates the health effects of in utero diethylstilbestrol (DES) exposure.  DES is a synthetic estrogen that was given to pregnant women in the 1950's and 1960's to prevent miscarriage. DES exposure has been linked to the development of vaginal/cervical clear cell adenocarcinoma in DES-exposed daughters, and to reproductive tract abnormalities in both daughters and sons of mothers who took the medication 		 
  Helen Kim, MD:
is currently investigating the molecular mechanisms involved in the regulation of the mouse GnRH gene. 		 Research: Section of Reproductive Endocrinology & Infertility
  Ernst Lengyel, MD, PhD:
investigates the interaction of proteolysis and adhesion in ovarian cancer and identifies targets for treatment. Towards this end cell culture and mouse models are used to test agents that inhibit ovarian cancer invasion and metastasis 		Lengyel Lab
  Stacy Tessler Lindau, MD, MAPP:
 runs an interdisciplinary research laboratory for clinical, population-based and registry research on aging and women's gynecologic health funded primarily by external grants from NIH/NIA and the American Geriatrics Society.  The research program studies:
  • reciprocal effects of social life, intimacy and sexuality and: 1) aging; 2) cancer survivorship; 3) sensory and cognitive functioning; 4) acute and chronic illness including HIV
  • methodologies for integration of biomedical (biomarkers) and social scientific methodologies to study health and illness in the population setting
  • medical education concerning sexuality, aging and ethical issues in women's health and health care. 
 Lindau Lab
  Marshall Lindheimer, MD: (emertius)
Dr. Lindheimer, a renal physiologist and nephrologist, focuses his research on hypertension and kidney disease in pregnancy. He is currently involved in clinical trials as a consultant for several World Health Organization trials and observational studies.  He is chair of General Clinical Research Center Advisory Board, whose functions include the units abilities include helping students, residents, fellows, and young investigators desiring to participate in clinical research
 
  Mary Mahowald, PhD: (emerita)
analyses of ethical and policy issues that arise in the medical setting, with particular attention to those that affect women and those related to advances in genetics. 		 
  Mary Stephenson, MD:
investigates factors associated with recurrent pregnancy loss, including but not limited to genetic, endocrine, autoimmune, thrombophilic, and idiopathic factors.  In addition, assess the effectiveness of therapies such as ASA, heparin and intravenous immunoglobulin (IVIG) to overcome reproductive loss.
Studies under the direction of Dr. Stephenson

Research: Section of Reproductive Endocrinology & Infertility

Recurrent Pregnancy Loss Program

 

Sarah Temkin, MD
Dr. Temkin's interests include the role of minimally invasive techniques on improving surgical outcomes in patients with gynecologic malignancies.  Additionally she is interested in clinical trials for patients with gynecologic cancer including the role of novel biologic therapies. 

 
  Mishka Terplan , MD:
Dr. Terplan has a background in epidemiology.  He is interested in meta-analysis and the secondary data analysis of large data bases.  In particular, his research focuses on women with drug and alcohol problems in pregnancy.  He involved with etiologic studies, such as the role of childhood sexual abuse in the development of substance addiction, as well as studies of clinical outcomes, for example, the effect of the adding interventions such as Motivational Interviewing to addiction treatment
 Section of Family Planning & Contraceptive Research
 

Diane Yamada, MD:
identification of the cellular pathways that regulate ovarian cancer metastasis critical to the development of improved therapeutic strategies.

Yamada Lab